In an end‑stage renal disease patient on chronic hemodialysis with recurrent heart failure, dilated cardiomyopathy, mild concentric left ventricular hypertrophy, pulmonary artery systolic pressure 65 mm Hg and ejection fraction 46 %, which medication should be initiated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the treatment for a patient with chronic heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease stage 4 (CKD 4)?
What is the recommended management for a patient with Chronic Kidney Disease (CKD) and Heart Failure with Reduced Ejection Fraction (HFrEF)?
What is the most appropriate approach for an 86-year-old woman with severe heart failure (ejection fraction of 15%) and chronic renal failure, experiencing progressive weakness, fatigue, and poor quality of life?
What is the best management approach for a patient with Benign Prostatic Hyperplasia (BPH), Heart Failure with Reduced Ejection Fraction (HFrEF), and End-Stage Renal Disease (ESRD)?
Do patients with Heart Failure with Reduced Ejection Fraction (HFrEF) undergoing hemodialysis require low Blood Flow Rates (BFR) and Dialysate Flow Rates (DFR)?
For an elderly cataract surgery patient with a lidocaine toxicity/allergy, which amide local anesthetic—mepivacaine or bupivacaine—offers a safer peribulbar block?
In an adult patient under critical‑care monitoring, what does a mixed venous oxygen saturation of 66 % indicate?
What is the recommended dosing, contraindications, and monitoring for Mirabegron in adults with overactive bladder, including dose adjustments for renal or hepatic impairment and precautions in uncontrolled hypertension?
What is the appropriate dosing, contraindications, and precautions for repaglinide in an adult with type 2 diabetes?
How rare is chronic myelomonocytic leukemia (CMML) (a MDS/MPN)?
What could cause foul, rotten‑egg smelling intestinal gas and how should it be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.